244 related articles for article (PubMed ID: 35927254)
1. Molecular characterization of colorectal cancer related peritoneal metastatic disease.
Lenos KJ; Bach S; Ferreira Moreno L; Ten Hoorn S; Sluiter NR; Bootsma S; Vieira Braga FA; Nijman LE; van den Bosch T; Miedema DM; van Dijk E; Ylstra B; Kulicke R; Davis FP; Stransky N; Smolen GA; Coebergh van den Braak RRJ; IJzermans JNM; Martens JWM; Hallam S; Beggs AD; Kops GJPL; Lansu N; Bastiaenen VP; Klaver CEL; Lecca MC; El Makrini K; Elbers CC; Dings MPG; van Noesel CJM; Kranenburg O; Medema JP; Koster J; Koens L; Punt CJA; Tanis PJ; de Hingh IH; Bijlsma MF; Tuynman JB; Vermeulen L
Nat Commun; 2022 Aug; 13(1):4443. PubMed ID: 35927254
[TBL] [Abstract][Full Text] [Related]
2. Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
Ubink I; van Eden WJ; Snaebjornsson P; Kok NFM; van Kuik J; van Grevenstein WMU; Laclé MM; Sanders J; Fijneman RJA; Elias SG; Borel Rinkes IHM; Aalbers AGJ; Kranenburg O
Br J Surg; 2018 Jan; 105(2):e204-e211. PubMed ID: 29341165
[TBL] [Abstract][Full Text] [Related]
3. Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases.
Bootsma S; Dings MPG; Kesselaar J; Helderman RFCPA; van Megesen K; Constantinides A; Moreno LF; Stelloo E; Scutigliani EM; Bokan B; Torang A; van Hooff SR; Zwijnenburg DA; Wouters VM; van de Vlasakker VCJ; Galanos LJK; Nijman LE; Logiantara A; Veenstra VL; Schlingemann S; van Piggelen S; van der Wel N; Krawczyk PM; Platteeuw JJ; Tuynman JB; de Hingh IH; Klomp JPG; Oubrie A; Snaebjornsson P; Medema JP; Oei AL; Kranenburg O; Elbers CC; Lenos KJ; Vermeulen L; Bijlsma MF
Cell Rep Med; 2024 May; 5(5):101523. PubMed ID: 38670098
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity.
Laoukili J; Constantinides A; Wassenaar ECE; Elias SG; Raats DAE; van Schelven SJ; van Wettum J; Volckmann R; Koster J; Huitema ADR; Nienhuijs SW; de Hingh IHJT; Wiezer RJ; van Grevenstein HMU; Rinkes IHMB; Boerma D; Kranenburg O
Br J Cancer; 2022 Jun; 126(12):1824-1833. PubMed ID: 35194192
[TBL] [Abstract][Full Text] [Related]
5. Management of colorectal cancer patients at high risk of peritoneal metastases.
Shariff U; Seretis C; Youssef H
J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
[TBL] [Abstract][Full Text] [Related]
6. Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer.
Shin W; Yun J; Han K; Park DG
Genes Genomics; 2023 Aug; 45(8):989-1001. PubMed ID: 37277571
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
Baratti D; Kusamura S; Iusco D; Gimondi S; Pietrantonio F; Milione M; Guaglio M; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
Ann Surg Oncol; 2017 Jan; 24(1):167-175. PubMed ID: 27519353
[TBL] [Abstract][Full Text] [Related]
8. Targeting Hyaluronic Acid and Peritoneal Dissemination in Colorectal Cancer.
Soliman F; Ye L; Jiang W; Hargest R
Clin Colorectal Cancer; 2022 Jun; 21(2):e126-e134. PubMed ID: 34955378
[TBL] [Abstract][Full Text] [Related]
9. Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
Klaver CEL; van Huijgevoort NCM; de Buck van Overstraeten A; Wolthuis AM; Tanis PJ; van der Bilt JDW; Sagaert X; D'Hoore A
Ann Surg Oncol; 2018 Jan; 25(1):212-220. PubMed ID: 29076043
[TBL] [Abstract][Full Text] [Related]
10. Decellularized extracellular matrix as scaffold for cancer organoid cultures of colorectal peritoneal metastases.
Varinelli L; Guaglio M; Brich S; Zanutto S; Belfiore A; Zanardi F; Iannelli F; Oldani A; Costa E; Chighizola M; Lorenc E; Minardi SP; Fortuzzi S; Filugelli M; Garzone G; Pisati F; Vecchi M; Pruneri G; Kusamura S; Baratti D; Cattaneo L; Parazzoli D; Podestà A; Milione M; Deraco M; Pierotti MA; Gariboldi M
J Mol Cell Biol; 2023 Apr; 14(11):. PubMed ID: 36460033
[TBL] [Abstract][Full Text] [Related]
11. Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Sluiter NR; de Cuba EM; Kwakman R; Meijerink WJ; Delis-van Diemen PM; Coupé VM; Beliën JA; Meijer GA; de Hingh IH; te Velde EA
Clin Exp Metastasis; 2016 Apr; 33(4):297-307. PubMed ID: 26873137
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer.
Buikhuisen JY; Gomez Barila PM; Cameron K; Suijkerbuijk SJE; Lieftink C; di Franco S; Krotenberg Garcia A; Uceda Castro R; Lenos KJ; Nijman LE; Torang A; Longobardi C; de Jong JH; Dekker D; Stassi G; Vermeulen L; Beijersbergen RL; van Rheenen J; Huveneers S; Medema JP
J Exp Clin Cancer Res; 2023 Mar; 42(1):56. PubMed ID: 36869386
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
[TBL] [Abstract][Full Text] [Related]
14. Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.
de Cuba EM; Kwakman R; van Egmond M; Bosch LJ; Bonjer HJ; Meijer GA; te Velde EA
Virchows Arch; 2012 Sep; 461(3):231-43. PubMed ID: 22825001
[TBL] [Abstract][Full Text] [Related]
15. The molecular biology of peritoneal metastatic disease.
Bootsma S; Bijlsma MF; Vermeulen L
EMBO Mol Med; 2023 Mar; 15(3):e15914. PubMed ID: 36700339
[TBL] [Abstract][Full Text] [Related]
16. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
de Cuba EM; Kwakman R; Knol DL; Bonjer HJ; Meijer GA; Te Velde EA
Cancer Treat Rev; 2013 Jun; 39(4):321-7. PubMed ID: 23244778
[TBL] [Abstract][Full Text] [Related]
17. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases.
Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N
World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097
[TBL] [Abstract][Full Text] [Related]
18. Palliative surgery for colorectal cancer with peritoneal metastasis: a propensity-score matching analysis.
Jeong SJ; Yoon YS; Lee JB; Lee JL; Kim CW; Park IJ; Lim SB; Yu CS; Kim JC
Surg Today; 2017 Feb; 47(2):159-165. PubMed ID: 27549772
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer: Metastases to a single organ.
Vatandoust S; Price TJ; Karapetis CS
World J Gastroenterol; 2015 Nov; 21(41):11767-76. PubMed ID: 26557001
[TBL] [Abstract][Full Text] [Related]
20. Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.
Vassos N; Piso P
Curr Treat Options Oncol; 2018 Sep; 19(10):49. PubMed ID: 30173342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
